Older individuals up to the age of 80 who are eligible for lung surgery may achieve a survival benefit from lung cancer screening comparable to that for younger patients, according to the results of a multicenter cohort study from the United Kingdom presented at the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on Lung Cancer (WCLC; Abstract PL03.19).

Consumers can now purchase Exact Sciences’ liquid biopsy early detection test, Cancerguard, and get an indication of whether they might have one of 50 different cancers included in the test’s analysis.

Getting a cancer diagnosis can be overwhelming and frightening. This guide is designed to help you understand liver cancer and equip you with the right questions to ask your medical team.

Appendix cancer is a condition that, until recently, was so rare that most people never gave it a second thought.

Sociodemographic factors may influence cancer survivors’ ability to access pharmacologic treatment for mental health conditions, according to study results.

A new blood test can identify cancers of the head and neck caused by the human papillomavirus (HPV) up to 10 years before symptoms appear.

Among patients with hormone receptor-positive (HR+), HER2-negative (HER2-) early breast cancer, the 70-gene profiling test MammaPrint has been found to be predictive of both distant recurrence-free interval prognosis and chemotherapy benefit, researcher has shown.

Primary care physicians may be underutilized in follow-up and surveillance of individuals with cancer.

Computed tomography (CT) scans are an important tool for diagnosing conditions and injuries by creating three-dimensional images.

Many Americans take a dark view of nicotine. The stimulant, which occurs naturally in tobacco plants, is what makes cigarettes so addictive, with smoking responsible for 490,000 American deaths each year.